SOST and type 2 diabetes mellitus: Additionally, it has been noticed that exendin-4 decreased the mRNA and protein levels of SOST-sclerostin in osteocyte-like MLO-Y4 cells, and also reduced the serum sclerostin level in T2D OLEFT rats.